Plus therapeutics to present at medinvest oncology investor conference

Austin, texas, dec. 02, 2021 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that marc h. hedrick m.d., president and chief executive officer of plus therapeutics, will present a company overview during the medinvest oncology investor conference on tuesday, december 7th at 12:00 p.m. et.
PSTV Ratings Summary
PSTV Quant Ranking